Opendata, web and dolomites


Can human embryo-released extracellular vesicles govern endometrial receptivity and inform on vanguard embryo diagnostics and fertility therapeutics?

Total Cost €


EC-Contrib. €






 CERVINO project word cloud

Explore the words cloud of the CERVINO project. It provides you a very rough idea of what is the project "CERVINO" about.

biopsy    inspire    evs    pgs    aneuploid    profile    embryos    cells    fertilisation    release    potentiates    implantation    natural    negate    biomarkers    embryo    community    biopsies    receptivity    prior    screen    sequencing    mount    therapeutic    utilised    reported    gene    vitro    function    genes    collectively    pilot    scrutinise    material    introduce    showed    consequently    internalised    paramount    utilising    cutting    whereby    rnaseq    upregulation    preimplantation    revealed    instead    screening    ecs    euploid    potentially    therapeutics    vesicles    controversial    ev    group    edge    host    acquisition    compromise    internalisation    single    endometrial    tackle    had    effect    transfer    consequence    first    human    uterine    functional    genome    harmful    methodology    cell    transcriptome    quality    cargo    delineating    select    demonstrated    characterise    pathophysiology    primary    exported    invasive    poor    establishment    throughput    extracellular    biosafety    abundance    ivf    genetic    mechanistic    innovators    transcriptomic    additionally    time   

Project "CERVINO" data sheet

The following table provides information about the project.


Organization address
address: VIA OLGETTINA 60
city: MILANO
postcode: 20132

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Total cost 180˙277 €
 EC max contribution 180˙277 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2017
 Funding Scheme MSCA-IF-EF-SE
 Starting year 2018
 Duration (year-month-day) from 2018-07-02   to  2020-07-01


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    OSPEDALE SAN RAFFAELE SRL IT (MILANO) coordinator 180˙277.00


 Project objective

Preimplantation Genetic Screening (PGS) based on high-throughput embryo genome sequencing is currently utilised in In Vitro Fertilisation (IVF) to select for euploid embryos prior to uterine transfer in order to increase implantation potential. The methodology for the acquisition of genetic material is controversial, as the invasive embryo biopsy required for PGS may compromise embryo quality. Moreover its long-term biosafety has not been evaluated. Consequently, the development of non-invasive methods to screen out aneuploid embryos is paramount. The host research group recently first reported that human IVF embryos release extracellular vesicles (EVs) and demonstrated their uptake by primary endometrial cells (ECs). Our pilot analysis of the embryo-derived EV transcriptome revealed an abundance of genes that may be involved in the establishment of endometrial receptivity. Additionally, our RNAseq on ECs, which had internalised human embryo-exported EVs, showed a gene-upregulation profile relevant to implantation. Collectively, our findings introduce a novel concept to the state-of-the-art whereby human embryos deliver a functional EV-transcriptomic cargo to ECs to mount an implantation response. Delineating the EV transcriptome, and studying the consequence of its delivery in ECs, potentiates mechanistic insight into the pathophysiology of implantation. The project will characterise for the first time the transcriptomic cargo of euploid and aneuploid human embryo-exported EVs and scrutinise the effect of its internalisation on endometrial function. This cutting-edge work may negate potentially harmful invasive embryo biopsies for PGS by instead utilising biomarkers in EVs – a ‘natural cell biopsy’. EV biomarkers could also inspire therapeutics to enhance endometrial receptivity. This programme is especially timely, as leading innovators in the field currently focus to provide the community with a single therapeutic approach to tackle poor endometrial function.


year authors and title journal last update
List of publications.
2018 Sofia Makieva, Elisa Giacomini, Jessica Ottolina, Ana Sanchez, Enrico Papaleo, Paola Viganò
Inside the Endometrial Cell Signaling Subway: Mind the Gap(s)
published pages: 2477, ISSN: 1422-0067, DOI: 10.3390/ijms19092477
International Journal of Molecular Sciences 19/9 2019-06-11

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CERVINO" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CERVINO" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

CarboPorph (2020)

Novel Cyclocarbon-Porphyrin Systems: Synthesis and Properties

Read More  

BrownianReactivation (2019)

Neural stochasticity and criticality in memory replay

Read More  

Print2fly (2019)

Can we print an aircraft at room temperature?

Read More